跳至主要内容
临床试验/EUCTR2018-004139-66-BE
EUCTR2018-004139-66-BE进行中(未招募)1 期

Effect of norepinephrine infusion on hepatic blood flow during goal-directed hemodynamic therapy.

Ghent University Hospital0 个研究点目标入组 28 人开始时间: 2019年3月25日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
28

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Adult = 18 years = 80 years (female or male)
  • ASA I – II – III
  • Able to comprehend, sign and date the written informed consent document to participate in the clinical trial.
  • Scheduled for pancreatic surgery.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 10
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 18

排除标准

  • Allergy to the medication.
  • Renal insufficiency (SCr > 2 mg/dL).
  • Severe heart failure (EF < 25%).
  • Hemodynamic instable patients.
  • Atrial fibrillation.
  • BMI > 40.
  • Severe coagulopathy (INR > 2).
  • Thrombocytopenia (< 80 x 103 /mcL).
  • End stage liver disease.
  • Pregnancy and breastfeeding women

研究者

相似试验